Cell-Receptor Transgenic Mice Involves Deletion of Nonmature CD4+8+ Thymocytes Pawel Kisielow"T, Horst Bliithmann*, Uwe D

Total Page:16

File Type:pdf, Size:1020Kb

Cell-Receptor Transgenic Mice Involves Deletion of Nonmature CD4+8+ Thymocytes Pawel Kisielow ~74~2---------------------------------------------ARfiCLES------------------------~N~A~T~U~R~E~v~c~Jl~.. ~3~33~2='~·~'t~JN~E~t~9=88 Tolerance in T -cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes Pawel Kisielow"t, Horst Bliithmann*, Uwe D. Staerz", Michael Steinmetz* & Harald von Boehmer" * Basel Institute for Immunology, CH-4005 Basel, Switzerland :j: Central Research Units, F. Hoffmann-La Roche & Co. Ltd, CH-4002 Basel, Switzerland The mechanism of self-tolerance is studied in T-cell-receptor transgenic mice expressing a receptor in many of their T cells for the male (H- Y) antigen in the context of class I H-2Db MHC antigens. Autospecific T cells are deleted in male mice. The deletion affects only transgene-expressing cells with a relatively high surface-density of CDS molecules, including nonmature CD4+CD8+ thymocytes, and is not caused by anti-idiotype cells. T LYMPHOCYTES recognize antigens on the surface of other products were absent from the pool of peripheral T cells and 12 14 cells in the context of molecules encoded by the major histocom­ medullary thymocytes - , but were present among cortical 1 12 13 patibility complex (MHC) by virtue of the heterodimeric T cell CD4+8+ thymocytes • . These results can be explained by receptor (TRC) which is composed of a and {3 polypeptide deletion of autospecific cells, but the alternative possibility that 2 3 chains • • In binding to its ligand, the a{3TCR is assisted by their absence is the result of a change of their phenotype caused 4 5 CD8 or CD4 accessory molecules • , which presumably interact by modulation or masking of surface molecules has not been with nonpolymorphic portions of class I or class II MHC excluded. 10 molecules respectivel/- • Mature T lymphocytes usually do The development of transgenic mice offers another approach not respond to self-MHC molecules presenting self-antigens. to analyse the mechanism of self-tolerance. To this end we have The question of whether the mechanism of immunological toler­ constructed transgenic mice expressing in a large fraction of ance involved deletion of autospecific lymphocytes has con­ their T cells an a{3TCR specific for a minor histocombatibility 1 cerned immunologists over decades \ but no direct evidence antigen (H-Y) present on male, but not female, cells. Fertilized for such a mechanism has been obtained, because the great eggs obtained from a cross of C57BL/6J x DBA/21 mice were diversity of receptors generated during lymphocyte development injected with genomic DNA harbouring the productively had made it impossible to follow individual clones of cells rearranged TCR a and {3 genes isolated from the B6.2.16 15 expressing receptors specific for self-antigens. cytolytic T-cell clone • This clone is specific for H-Y antigen Recently, two groups of investigators obtained monoclonal in the context of class I (H-2Db) MHC antigen and expresses antibodies (mAb) against the products of certain V{3 genes that a TCR {3-chain coded in part by the V{38.2 gene segment which 6 are expressed with unusually high frequency on T cells specific can be identified by the F23.1 antibodi . 12 14 for certain class II MHC-associated alloantigens - • Using The transgenic founder mouse 71 contained four copies of these antibodies, Kappler et al. and MacDonald et al. were able the a and two copies of the {3 transgenes integrated on the same 17 to show that in mice expressing the relevant class II MHC­ chromosome • It was crossed with C57L mice expressing H-2b associated antigens, cells expressing the particular V{3 gene MHC antigens, but lacking the V{38 gene family. Here we show that cells with the phenotype of the B6.2.16 clone that responded t Pennanent address: The Institute of Immunology and Experimental Therapy, Polish Academy to H-Y antigen were frequent in female but not in male trans­ of Sciences, Wroclaw, Poland. genic offspring, despite the fact that peripheral T cells in animals Table 1 Frequency of male (H-Y) antigen-specific precursors of proliferating T cells (PT-P) among CD4+8- and CD4-8+ T cells from normal and a/3TCR transgenic mice Donor of responding T cells af3TCR transgenic C57L Stimulation: female female male spleen cells CD4/CD8 (3000R) + IL-2 phenotype 1/frequency p* 1/frequency p !/frequency p C57BL/6 female CD4-8+ >25,000 >25,000 >25,000 C57BL/6 female CD4-8+ 2.3 (1.6-3.3) 0.66 1.8 (1.2-2.6) 0.87 2.3 (1.3-4.0) 0.18 +Con A CD4+8- NTt 6.4 (4.5-9.1) 0.60 NTt C57BL/6 male CD4-8+ 15,985 (5,029-50,802) 0.61 6.6 (4.8-9.0) 0.67 >25,000 CD4+8- NTt >25,000 NTt Lymph node cells were stained with a mixture of anti CD4-PE and anti-CD8-FITC mabs (see Fig. 1). CD4+8- and CD4-CD8+ T cells were separated on fluorescein activated cell sorter (FACS440, Becton Dickinson). Limiting numbers of CD4+8- CD4-8+ T cells (24 wells per group) were cultured for 8 days together with irradiated (3,000R) spleen cells (5 x 105 cells per cell) and interleukin-w (5% v/v) of partially purified 24 1 supernatant from Con A-stimulated rat spleen cells without or with Con A (2.5 f.Lg ml- ). Cells were collected after addition of eHJthymidine for the last 12 h of culture and incorporated radioactivity was measured by liquid scintillation counting. Negative control cultures contained no 25 responder cells. Frequencies were calculated as described elsewhere • * Probability, p, attached to the computed x2 (ref. 25). t NT, not tested. © 1988 Nature Publishing Group ~NA~TU~R=E~v~o=L~·~33~3~2~3~JU~N~E~t9~8~8------------------------ARTICL£S~-----------------------------------------7~43 17 of both sexes expressed both transgenes • T cells in male (but Littermates Lymph node cells not female) mice had an abnormal CD4/CD8 phenotype: over 90% of T cells in male transgenic mice were CD4-s-, or a expressed only low levels of CDS molecules, and the numbers of CD4+8-T cells were very small. The cellular composition of non transgenic male thymuses revealed that this unusual phenotype of male peripheral T cells was the consequence of deletion of auto­ specific thymocytes expressing high levels of CDS molecules, predominantly cortical CD4+8+ thymocytes. The deletion pro­ Q) c0 b cess spared cells expressing low levels of CDS molecules, but Q) UJ UJ 0 a.. a.. affected the precursors of single positive CD4+s- cells that were (/) transgenic !!' <t 0 ;;; not male-specific. This latter observation provides strong (\J 0 female ..2 evidence that double-positive CD4+8+ thymocytes contain pre­ u. y '0 ~ cursors of single positive CD4+s- and CD4-s+ T cells. ~ l'<l 0> 0 T cells in females ....J c Lymph nodes of female transgenic mice contained normal pro­ portions of CD4+8- and CD4-s+ T (Thy!+) cells which had transgenic normal levels of CD4 as well as CDS accessory molecules (Fig. male 1 a, b, d and e). But these differed in two respects from T cells in normal mice. Firstly, as previously described for~ transgenic 15 mice , most of them expressed the transgenic~ chain on their anti-Thy 1 ( FITC) anti-CD8 ( FITC) surface (Fig. 1 b). Secondly, as shown by limiting dilution analy­ Log green fluorescence sis of CD4-8+ T cells, one in six proliferated specifically in response to C57BL/ 6 male stimulator cells, as compared with Fig. 1 Comparison of cell surface expression of F23.1 + TCR f3 one in 16,000 in normal C57L female mice (see Table 1). As chain, CD4 and CDS molecules on lymph node T (Thy!+) cells only every second plated T cell responded to concanavalin A from female and male af3TCR transgenic mice and their nontrans­ (Con A), we conclude that at least 30% of CD4-s+ T cells in genic male littermate as analysed by two-colour flow cytometry. Lymph node cells were stained with biotinylated F23.1 monoclonal transgenic females have a phenotype similar to that of the antibody (mAb) followed by a mixture of fluorescein (FITC)­ B6.2.16 clone. CD4+8- T cells from transgenic mice did not labelled anti-Thy! mab with phycoerythrin-streptavidin (PEA) (a, show any male-specific proliferation, but did respond to Con band c) or with PE-conjugated anti-CD4 mAb followed by FITC A (Table 1). conjugated anti-CD8 mab ( d, e and fl. In panels a, b and c some Thy!- cells (B cells) stain nonspecifically with F23.1 mAb due to T cells in males the binding by Fe receptor. The presented data were obtained with As in transgenic females, lymph nodes of transgenic males one pair of 7-week-old af3TCR transgenic female and male litter­ contained normal proportions of Thyl + cells, and most of them mates. The same results were obtained with 3 other pairs of trans­ genic mice. expressed the transgenic ~ chain on their surface (Fig. lc). Methods. Single cell suspensions were prepared from lymph nodes Northern blot analysis of the a trans gene revealed comparable 17 (mesenteric, axillary, inguinal) and washed twice in RPM1-1640 levels of expression in T cells from female and male mice • and once in PBS with 5% FCS. For staining the following mAbs However, the CD4/CD8 phenotype ofT cells in male mice was were used: FITC-conjugated anti-Thy! (ref. 21), biotin-conjugated very different from that of females: 58% of Thy!+ cells were F23.1 (ref. 16), PE-conjugated anti-CD4 (anti-mouse L3T4, Becton CD4-s-, 35% were CD4-8+ but expressed low levels of CDS, Dickinson) FITC conjugated anti-CD8 (anti-mouse Lyt2, Becton and 7% were CD4+8- and expressed normal amounts of CD4 Dickinson).
Recommended publications
  • Differential Synergy of Notch and T Cell Receptor Signaling Determines Αβ
    ARTICLE Diff erential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage fate Annette I. Garbe,1 Andreas Krueger,1 Fotini Gounari,1,2 Juan Carlos Zúñiga-Pfl ücker,3 and Harald von Boehmer1 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 2Tufts-New England Medical Center, Boston, MA 02111 3University of Toronto, Toronto, Ontario, M4N 3M5 Canada Thymic precursors expressing the pre–T cell receptor (TCR), the TCR, or the TCR can all enter the CD4+8+ lineage, albeit with different effi cacy. Here it is shown that proliferation and differentiation of precursors with the different TCRs into lineage cells require Notch signaling at the DN3 stage of thymic development. At the DN4 stage, Notch signaling still signifi cantly contributes to the generation of T cells. In particular, in lineage commitment, the pre-TCR synergizes more effi ciently with Notch signals than the other two TCRs, whereas TCR-expressing cells can survive and expand in the absence of Notch signals, even though Notch signaling enhances their proliferation. These observations suggest a new model of versus lineage choice in which lineage fate is determined by the extent of synergy between TCR and Notch signaling and in which the evolutionarily recent advent of the cell-autonomously signaling pre-TCR increased the effi cacy of T cell generation. CORRESPONDENCE The mammalian immune system contains sev- essential for the rescue of DP cells from pro- Harald von Boehmer: eral T lymphocyte lineages of which the grammed cell
    [Show full text]
  • Deciphering Thymic Development
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE OPINION ARTICLE published: 08provided October by 2014 Frontiers - Publisher Connector doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5). This surprised though one cannot be completely sure of B cells as well as Rosenthal and Shevach some molecular biologists somewhat who it. So Georges did not produce the mice (3) describing it for the interaction of T thought that the cloning of the TCR put but Anton Berns in Amsterdam cooper- cells with macrophages.
    [Show full text]
  • Table of Contents
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]
  • April 8, 1997, NIH Record, Vol. XLIX, No. 7
    C 0 R a Still The Second Best Thing About Payday Record Debuts on the Web HIGHLIGHTS· From 'Whatchamacallit' to Funshine New Camp Starts for Children The NIH Record, exclusively a paper publication since May 1949, is now Special love Infected with HIV available electronically on the World Wide launches New By Rich McManus Web. It can be accessed within the NIH Camp home page (www.nih.gov) under the nless you just came to NIH a week ago, you probably know at " Information for Employees" and "News Microsoft least something about Camp Fantastic. For the uninitiated, it's and Events" sections. Or open the site Wunderkind ~ a week-long slice of August turned into terrific summer camp directly by going to http://www.nih.gov/ Foretells Future for children-many of them Clinical Center patients-with cancer, news/NIH-Record/archives.htm. and has always been powered by the freehearted and funloving Catch the Record side of the National Cancer Institute-its Pediatric Branch and The Web version is modeled after the on the Web associated caregivers. It began 15 years ago at a 4-H campground paper one and closely resembles it, but has near Front Royal, Va., and has evolved into a year-round, family­ the advantage of color design and centered program that worries not just about the child with photography. The site's opening page is an cancer, but also about the healthy sibling who wonders where all " Archives" of issues that leads off-for the Dyer, Gorgas Talks of mom and dad's attention went.
    [Show full text]
  • Shaping the T Cell Repertoire
    Shaping the T Cell Repertoire Harald von Boehmer J Immunol 2005; 175:7067-7068; ; This information is current as doi: 10.4049/jimmunol.175.11.7067 of September 27, 2021. http://www.jimmunol.org/content/175/11/7067 Downloaded from References This article cites 6 articles, 3 of which you can access for free at: http://www.jimmunol.org/content/175/11/7067.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts Errata An erratum has been published regarding this article. Please see next page or: /content/176/1/677.1.full.pdf /content/176/1/677.2.full.pdf The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Shaping the T Cell Repertoire Harald von Boehmer1 Today immunologists are well aware of positive to self. In this hypothesis, the focus on self-MHC was imposed and negative selection of developing T cells.
    [Show full text]
  • Harald Von Boehmer 1942–2018
    obituary Harald von Boehmer 1942–2018 oday, few topics in immunology Notch family of signaling receptors in this receive more attention than efforts malignancy. With colleagues in the lab, Tto detect, induce or reinvigorate the Harald also published important insights immune response to tumors. Although into the mechanisms through which many types of immune cells affect different T cell populations respond to and contribute to anti-tumor immune tumors and destroy pancreatic β -cells. At responses, the initial clinical findings that the same time, he never stopped pursuing electrified the field focused on the T cell. knowledge of the basic mechanisms that Cancer biologists who grabbed the nearest affect T cell development. While in Boston, immunology textbook in an effort to fully his lab described mechanisms that affect comprehend and build upon those initial the development of regulatory T cells in the clinical successes will have quickly realized thymus and the periphery and continued that at their core, such approaches rely on to publish insights into the structure and understanding how T cells recognize and function of the pre-TCR. respond to antigen. What they may not After closing his Boston lab, Harald have realized is how important Harald returned to his alma mater as a guest von Boehmer’s work was in laying the professor at the Institute for Immunology foundation for this understanding. of the Ludwig Maximilian University in Long before translational research was Munich. In his writings during this period, all the rage, Harald charged a segment of between the TCR and peptide–major Harald expressed optimism about the future his lab with investigating how fundamental histocompatibility complex determined of immunological research.
    [Show full text]
  • Deciphering Thymic Development
    Deciphering Thymic Development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Von Boehmer, Harald. 2014. “Deciphering Thymic Development.” Frontiers in Immunology 5 (1): 424. doi:10.3389/fimmu.2014.00424. http://dx.doi.org/10.3389/fimmu.2014.00424. Published Version doi:10.3389/fimmu.2014.00424 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347532 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA OPINION ARTICLE published: 08 October 2014 doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5).
    [Show full text]
  • The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency
    The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency The Rockefeller University New York, NY April 17–20, 2013 Henry George Kunkel 1916–1983 enry Kunkel received his B.S. degree from Princeton and his M.D. degree from Johns Hopkins University. He arrived at The Rockefeller Institute (now University) in 1945 where he spent his entire scientific career H until his death in 1983. His contributions to the field of basic and clinical immunology are legendary. He made numerous seminal observations in liver disease, rheumatic diseases and other allied disorders. He was perhaps best known for his pioneering and extensive studies on the immunoglobulins. His recognition that myeloma proteins were a model for the study of the structure of normal immunoglobulins had a global impact on investigations of the structure, function and inheritance of these molecules. The elucidation of the chain structure of gamma globulin and the recognition that immunoglobulins possessed individual antigenic specificity (idiotypes) were internationally recognized discoveries. Dr. Kunkel was the recipient of many awards and honors, including membership in the National Academy of Sciences, honorary degrees from Universities of Uppsala and Harvard, and recipient of the Lasker and Gairdner Awards and the Kovalenko Medal of the National Academy of Sciences. Henry Kunkel Society Officers Henry Kunkel Society Lecturers President ................Westley Reeves 1992. Louis Kunkel 2003. .Fred Rosen Vice President ...............Keith Elkon 1993. .David Ho 2004. .Diane Mathis Secretary ........... Michel Nussenzweig 1994. Benvenuto Pernis 2005. Charles Weissman Treasurer ...............Anne Marshak- 1996. Jeffrey Ravetch 2006. Ralph M. Steinman Rothstein 1997. Anthony Fauci 2007.
    [Show full text]
  • The Paul Ehrlich Foundation
    The Paul Ehrlich Foundation Office of the Paul Ehrlich Foundation Contents Paul Ehrlich-Stiftung c/o Vereinigung von Freunden und Förderern der Goethe-Universität Theodor-W.-Adorno-Platz 1 Preface 5 60629 Frankfurt am Main E-Mail: [email protected] www.paul-ehrlich-stiftung.de Paul Ehrlich: His Life March 2021 and Achievements 6 Ludwig Darmstaedter: Donation account: Scientist and Friend 12 Deutsche Bank AG IBAN: DE38 5007 0010 0700 0839 00 BIC: DEUTDEFFXXX The Foundation, the Prize and the Role of Hedwig Ehrlich 14 The Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers 17 Preface In honor of the great German doctor and Paul Ehrlich, like all great researchers, was serologist who turned Frankfurt into a way ahead of his time. His research work medical eldorado at the beginning of the laid the cornerstone for the medical stand- 20th century, the Paul Ehrlich and Ludwig ards still valid today. In awarding the Paul Darmstaedter Prize is awarded to scientists Ehrlich and Ludwig Darmstaedter Prize, the from all over the world who have achieved Foundation wishes to encourage scientists all outstanding results in Paul Ehrlich’s field over the world to do what Paul Ehrlich did of work. throughout his entire life: extend medical know-how and make a contribution to the The prize given by the Paul Ehrlich constant struggle against illness and disease- Foundation is one of Germany’s most emi- induced mortality. nent accolades in recognition of outstand- ing achievements in biomedical research. The President of the German Research Foundation (DFG) is Honorary President of the Paul Ehrlich Foundation.
    [Show full text]
  • Immunology in Germany German Society for Immunology
    1901 1984 Emil von Behring Georges J.F. Köhler Nobelprize ‘for his work on serum Nobelprize therapy, especially its ‘for theories application against concerning the diphtheria, by which specificity in 2008 he has opened a new 1905 development and Harald zur road in the domain of Robert Koch control of the Hausen medical science and 1908 immune system thereby placed in the Nobelprize Paul Ehrlich and the discovery Nobelprize hands of the physician ‘for his investigations of the principle ‘for his discovery of a victorious weapon and discoveries in Nobelprize for production human papilloma against illness and relation to ‘in recognition of his of monoclonal viruses causing deaths’ tuberculosis’ work on immunity’ antibodies’ cervical cancer’ Immunology in Germany German Society for Immunology Content Preface ............................................................................... 3 About the DGfI ...................................................................4 Academy of Immunology ...................................................6 Research Focus Groups ......................................................7 Scientific Awards ................................................................8 Annual Meeting ...............................................................10 International Networks & Bilateral Meetings ..................11 Immunology in Germany - Overview ..............................12 Public Outreach - ‚Immunology for Everyone‘ ................16 Membership in the DGfI? Yes! .........................................17
    [Show full text]
  • How Does the Immune System Learn to Distinguish Between Good and Evil? the First Definitive Studies of T Cell Central Tolerance and Positive Selection
    Immunogenetics (2019) 71:513–518 https://doi.org/10.1007/s00251-019-01127-8 REVIEW How does the immune system learn to distinguish between good and evil? The first definitive studies of T cell central tolerance and positive selection Paweł Kisielow1 Received: 30 July 2019 /Accepted: 3 August 2019/Published online: 15 August 2019 # The Author(s) 2019 Abstract Demonstration that immature CD4 + 8+ thymocytes contain T cell precursors that are subjected to positive and negative selection was the major step towards understanding how the adaptive immune system acquires the ability to distinguish foreign or abnormal (mutated or infected) self-cells from normal (healthy) cells. In the present review, the roles of TCR, CD4, CD8, and MHC molecules in intrathymic selection and some of the crucial experiments that contributed to the solution of the great immunological puzzle of self/ nonself discrimination are described in an historical perspective. Recently, these experiments were highlighted by the immunological community by awarding the 2016 Novartis Prize for Immunology to Philippa Marrack, John Kappler, and Harald von Boehmer. Keywords Tcells . Positive and negative selection . Self/nonself discrimination Introduction 1959; Peter Medawar, 1960; Gerald Edelman and Roney Porter, 1972; Baruj Benaceraff, Jean Dausset, and George The “Good” that is protected by the immune system consists Snell, 1983; Niels Jerne, George Koehler, and Cesar Milstein of properly functioning healthy cells, and the “Evil” that is 1984; Susumu Tonegawa, 1987; Peter Doherty
    [Show full text]
  • Table of Contents (PDF)
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]